If you suspect someone is having a myocardial infarction, the recommended aspirin dose is 162 to 325 mg of non-enteric-coated aspirin, chewed rather than swallowed whole, given as soon as possible unless the person has a documented allergy, active bleeding, or another clear contraindication. Both the American Heart Association and the European Society of Cardiology converge on this range for suspected ST-elevation myocardial infarction. Call emergency services first β aspirin is an adjunct to reperfusion, not a substitute for it.
Why 162 mg Is the Floor and 325 mg Is the Ceiling
The lower bound of 162 mg comes from the smallest tablet size that reliably produces rapid, near-complete platelet cyclooxygenase-1 inhibition when chewed. Bayer's chewable aspirin is sold as 81 mg tablets in the United States, so the practical instruction is two tablets β 162 mg β as the minimum. The upper bound of 325 mg reflects the standard full-strength adult tablet in North America; the AHA's 2010 guideline update and its subsequent emergency-care statements describe 162 to 325 mg as the accepted prehospital range.
Above 325 mg, you gain nothing in acute platelet suppression and you raise gastrointestinal and bleeding risk. The dose-response curve for COX-1 inhibition in platelets is steep and saturates well below 325 mg; a 500 mg tablet does not make platelets more inhibited than a 325 mg one. That is why you will not see "give 650 mg" in any major STEMI protocol.
The range exists because tablet strengths differ by country. In the United States, 81 mg and 325 mg dominate. In the United Kingdom and much of Europe, 75 mg and 300 mg are the standard strengths, and the ESC's STEMI guidance points to 150 to 300 mg chewed or crushed for patients not already on aspirin. If you are holding a 75 mg tablet, four of them land at 300 mg β inside both the American and European windows.
Region matters more than most first-aid summaries admit. A traveler in Germany with a pack of 100 mg aspirin should give three tablets (300 mg); a traveler in the US with 81 mg chewables should give two to four. The rule is the milligram total, not the tablet count.
The Exact Sequence When Infarction Is Suspected
Emergency dispatch first, then aspirin. That order is not bureaucratic β dispatchers can coach CPR, confirm contraindications, and route the nearest advanced life support unit while you are still opening the bottle. The AHA'sζ₯ζ chain of survival places recognition and calling ahead of any self-administered medication.
1: Call your local emergency number (911 in the US, 999 in the UK, 112 across the EU) and say "possible heart attack." Stay on the line. 2: Confirm the person is conscious, breathing, and not vomiting blood, and ask whether they have a known aspirin allergy, a bleeding disorder, or a recent GI bleed. 3: Check for aspirin at 162β325 mg in non-enteric-coated form. Enteric-coated tablets are designed to dissolve in the intestine and are too slow for this setting. 4: Have the person chew the tablet(s) thoroughly β chewing bypasses the stomach's dissolution step and gets salicylate into the portal circulation within roughly 5 to 10 minutes. 5: Keep them seated or reclining, loosen tight clothing, and stay with them until EMS arrives. Do not let them walk to the car.
Failure handling is where most well-meaning bystanders go wrong. If the person is allergic, give nothing and tell the dispatcher. If they are unconscious or cannot swallow safely, do not place aspirin in the mouth β aspiration risk outweighs the benefit. If they have already taken aspirin today, do not stack a second full dose on top without dispatcher guidance. If the only aspirin available is enteric-coated, give it anyway and say so to the paramedics; a delayed dose beats no dose. And if the person is on warfarin, a direct oral anticoagulant, or has had a recent stroke with bleeding, the decision shifts to the clinician β the dispatcher can relay this.
What the Landmark Trials Actually Showed About Early Aspirin
The single most important trial for this question is ISIS-2, published in The Lancet in 1988. It randomized over 17,000 patients with suspected acute myocardial infarction to aspirin 162.5 mg, streptokinase, both, or neither. Aspirin alone reduced 35-day vascular mortality by 23 percent; the combination of aspirin plus streptokinase reduced it by 42 percent. That 162.5 mg figure is why 162 mg sits at the bottom of the modern range.
ISIS-2 also established that the benefit appears fast β within the first day β and that the absolute mortality reduction was roughly 2.4 per 100 patients treated with aspirin alone. That number is worth holding onto: it means early aspirin is one of the highest-yield interventions available to a bystander, but it still leaves the large majority of benefit to reperfusion, which is why the emergency call comes first.
The second trial worth naming is the Chinese Acute Stroke Trial's sibling work and, more relevantly, the Swedish Angina Pectoris Aspirin Trial context β but for MI specifically, the second anchor is the 2013 ACCF/AHA STEMI guideline, which formalized 162β325 mg chewed as a Class I recommendation for patients not already on aspirin. That guideline also specifies that patients already taking daily aspirin should receive 81 to 325 mg rather than a full new loading dose.
There is a persistent myth that the "right" dose is 300 mg because that is what European protocols say. Both 162.5 mg in ISIS-2 and 300 mg in European practice fall inside a range where COX-1 inhibition is essentially complete, so the difference is tablet logistics, not pharmacology. The one number that does matter is 0 mg β no aspirin at all β because that forfeits the 23 percent relative mortality reduction.
Chewed, Crushed, or Swallowed Whole: What Changes
Chewing is not folklore. A pharmacokinetic study in the Journal of the American College of Cardiology (the 2012 comparison of chewed versus swallowed 324 mg aspirin) found that chewing produced measurable platelet inhibition within about 5 to 10 minutes, while swallowing whole delayed meaningful inhibition to roughly 20 to 30 minutes and sometimes longer with food in the stomach. In a time-critical coronary occlusion, that 15-minute gap corresponds to measurable myocardial loss.
Crushing is an acceptable substitute if the person cannot chew β dissolve the powder in a small amount of water and have them drink it. Do not dissolve it in a large glass; the goal is a concentrated dose, not a beverage.
Enteric coating is the trap. These tablets carry a polymer shell that resists gastric acid so the drug releases in the small intestine, which is useful for chronic daily use and useless in an emergency. If the bottle says "enteric coated," "EC," or "safety coated," the onset is delayed and unreliable.
For children and adolescents, the picture is different and this article's 162β325 mg range does not apply. Suspected MI in a minor is rare and almost always Kawasaki-related or congenital; pediatric dosing is weight-based and must be directed by a clinician or dispatcher, never extrapolated from adult tables.
The Comparison That Decides: Formulation by Formulation
The practical decision in front of a bystander is not "which milligram" but "which bottle in the house works." Here is how the common retail forms stack up against the 162β325 mg target.
| Aspirin form | Typical tablet strength | Tablets needed for 162β325 mg | Onset when chewed | Fits the acute MI window |
|---|---|---|---|---|
| Chewable, non-enteric (US) | 81 mg | 2β4 | 5β10 minutes | Yes |
| Standard tablet, non-enteric (US) | 325 mg | 1 (or Β½ for 162 mg) | 5β10 minutes | Yes |
| Low-dose tablet (UK/EU) | 75 mg | 3β4 | 5β10 minutes | Yes |
| Standard tablet (UK/EU) | 300 mg | 1 | 5β10 minutes | Yes |
| Enteric-coated 81 mg | 81 mg | 2β4 | 20β30+ minutes | Discouraged |
| Buffered effervescent | 325 mg | 1 | 5β10 minutes | Yes, if fully dissolved |
The verdict is conditional. If you have chewable 81 mg, give two to four tablets. If you have a single 325 mg uncoated tablet, give one whole tablet and have them chew it. If you have 75 mg European tablets, give three to four. If the only thing in the cabinet is enteric-coated, give the equivalent milligram dose and tell EMS it was coated β do not skip it. The one form to actively avoid is buffered aspirin taken with a large glass of water without chewing, because the buffer does not accelerate absorption and the water volume slows gastric emptying.
When Aspirin Must Be Withheld
Aspirin is not a universal default. The AHA and ESC both carve out explicit contraindications, and a bystander who ignores them can do real harm.
Known aspirin or NSAID anaphylaxis is an absolute stop. So is active gastrointestinal bleeding, a recent hemorrhagic stroke, or a known bleeding disorder such as severe thrombocytopenia or hemophilia. Aspirin's irreversible COX-1 blockade lasts the lifespan of the platelet β 7 to 10 days β so a dose given today has antiplatelet consequences for over a week.
Relative cautions matter in the field. Patients on warfarin with a supratherapeutic INR, patients on a direct oral anticoagulant within 24 hours of dosing, and patients with known aortic dissection are all cases where the risk-benefit calculus belongs to a clinician. Aortic dissection is a specific trap: it can mimic MI, and aspirin worsens it. If the pain is described as tearing and radiating to the back, say so to the dispatcher before giving anything.
Age and pregnancy change the frame too. Aspirin at these doses is generally avoided in late pregnancy outside specialist direction because of ductus arteriosus and bleeding concerns, and in children under 16 it carries a Reye's syndrome association outside specific indications. Neither is a reason to withhold in a genuine adult MI, but both are reasons to let the dispatcher hear the details.
How the Dose Interacts With Reperfusion and Hospital Care
The prehospital aspirin dose is not a one-off; it feeds into the hospital pathway, and getting it right simplifies everything downstream. The 2013 ACCF/AHA STEMI guideline directs that patients receive 162β325 mg chewed before arrival when possible, and that the hospital record document the dose and time, because subsequent antiplatelet therapy β a P2Y12 inhibitor such as ticagrelor or prasugrel, or clopidogrel β is layered on top.
That layering is why dose documentation matters. If a patient arrives having taken 325 mg, the catheterization lab knows the aspirin load is complete. If they took 81 mg, the team may top up. In the ESC's 2017 STEMI guidance, the loading approach for aspirin in patients not already on it is 150 to 300 mg orally or intravenously, again inside the same window, and the IV formulation exists for patients who cannot swallow.
There is a genuine edge case worth flagging: patients already on daily low-dose aspirin who are having a suspected MI. The ACCF/AHA guideline says to give 81 to 325 mg rather than a new 325 mg loading dose, because their platelets are already partially inhibited and the marginal benefit of a large additional dose is small while the bleeding risk is not zero. This is the single most common real-world deviation from the "give 325 mg" instinct.
For patients who cannot take oral medication β vomiting, altered consciousness, intubated β intravenous aspirin at 150 to 300 mg is the hospital alternative, but it is not a bystander intervention. Do not attempt to administer anything by mouth to someone who cannot swallow safely.
The Numbers a Bystander Should Remember
Three figures compress the whole question. Use them to sanity-check any conflicting advice you encounter.
| Figure | What it means | Source |
|---|---|---|
| 162.5 mg | The ISIS-2 trial dose that cut 35-day vascular mortality by 23% | ISIS-2, The Lancet, 1988 |
| 162β325 mg | The AHA's recommended chewed range for suspected STEMI | 2013 ACCF/AHA STEMI guideline |
| 150β300 mg | The ESC's loading range for patients not on aspirin | 2017 ESC STEMI guidelines |
| 75 mg / 81 mg | The low-dose strengths that require 2β4 tablets to reach the window | Manufacturer labeling, US and UK |
The arithmetic is simple and worth doing out loud. Two 81 mg chewables = 162 mg, the floor. Four 81 mg chewables = 324 mg, effectively the ceiling. One 325 mg tablet = 325 mg. Three 75 mg tablets = 225 mg, comfortably inside. Four 75 mg tablets = 300 mg, the European standard.
What the numbers do not tell you is timing. The ISIS-2 mortality benefit was measured in patients treated early; the same 162.5 mg given hours later does less. That is the whole argument for acting in the first minutes, and it is why the sequence in this article puts the phone call before the pill bottle.
Common Mistakes That Undo the Benefit
The most frequent error is giving enteric-coated aspirin and believing the job is done. The coating delays absorption by 20 minutes or more, which in a coronary occlusion is myocardial you cannot get back. Check the label before you check the clock.
The second is dissolving aspirin in a full glass of water and having the person sip it slowly. Large volumes slow gastric emptying, and slow sipping spreads the dose over many minutes. Chew, or crush into a tablespoon of water and swallow.
The third is giving aspirin to someone who is already vomiting or drowsy. Aspiration risk is real, and an unconscious patient cannot protect their airway. Wait for EMS.
The fourth is doubling up out of anxiety. Aspirin's antiplatelet effect saturates; a second 325 mg does not add protection but does add bleeding risk. Give the range dose once, note the time, and stop.
The fifth is treating aspirin as the intervention rather than an adjunct. Reperfusion β PCI or fibrinolysis β is what reopens the artery. Aspirin buys time and reduces re-occlusion; it does not substitute for the catheterization lab. The AHA's chain of survival is explicit that definitive care, not medication, is the destination.
FAQ
Can I give aspirin if the person is already taking a daily 81 mg tablet?
Yes, but do not stack a full new 325 mg loading dose on top without dispatcher guidance. The 2013 ACCF/AHA STEMI guideline specifies 81 to 325 mg for patients already on aspirin, which means a single additional tablet in most cases rather than a fresh loading dose. Their platelets are already partially inhibited, so the marginal antiplatelet gain from a large extra dose is small while the bleeding risk is not.
Is 500 mg aspirin better than 325 mg in an emergency?
No. Platelet COX-1 inhibition saturates well below 325 mg, so a 500 mg tablet adds gastrointestinal and bleeding risk without adding antiplatelet effect. No major STEMI protocol recommends 500 mg as a target; the AHA ceiling is 325 mg. If 500 mg tablets are all you have, giving one still lands above the ceiling but inside a dose that works β the better move is to give it and tell EMS the strength.
What if the only aspirin I have is enteric-coated?
Give it anyway at the equivalent milligram dose and tell the paramedics it was coated. The coating delays absorption by roughly 20 to 30 minutes compared with chewed uncoated aspirin, so it is a worse option, but a delayed dose beats a skipped one. Do not try to scrape or crush the coating off a tablet to speed it up β you cannot reliably remove it, and you may just make the tablet harder to swallow.
Does aspirin help if the chest pain turns out to be something else?
It can, and it can also hurt. Aspirin is indicated for suspected MI because the downside of missing a real occlusion outweighs the downside of giving it to a patient who turns out to have angina or pericarditis. But in aortic dissection, which can mimic MI with tearing pain radiating to the back, aspirin worsens bleeding. That is why the dispatcher should hear the pain description before the tablet goes in the mouth.
How fast does chewed aspirin start working?
Measurable platelet inhibition appears within about 5 to 10 minutes of chewing an uncoated 324 mg tablet, compared with roughly 20 to 30 minutes when the same dose is swallowed whole. That gap is the pharmacokinetic basis for the chew instruction in every major STEMI guideline. Crushing and dissolving in a small amount of water produces a similar onset when chewing is not possible.
Can I give aspirin to a child or teenager with chest pain?
Not on the adult 162β325 mg schedule. Suspected MI in a minor is rare and usually tied to congenital or Kawasaki-related coronary disease, and pediatric dosing is weight-based and clinician-directed. Aspirin in children under 16 also carries a Reye's syndrome association outside specific indications. Call emergency services and let the dispatcher and receiving clinician set the dose.
What if the person is allergic to aspirin but is clearly having a heart attack?
Give nothing by mouth and tell the dispatcher immediately. Aspirin anaphylaxis is an absolute contraindication, and the hospital has alternatives β intravenous antiplatelet agents and, in some protocols, a P2Y12 inhibitor β that a bystander cannot administer. The dispatcher can pre-alert the receiving facility so the allergy is on the record before arrival.
Does the 162β325 mg range apply outside the United States?
The milligram range is broadly consistent, but tablet strengths differ. In the UK and much of Europe, 75 mg and 300 mg are the standard strengths, and the ESC's 2017 STEMI guidance names 150 to 300 mg as the loading range for patients not already on aspirin. Three to four 75 mg tablets (225β300 mg) or one 300 mg tablet both land inside the window. Check the label's milligram figure, not the tablet count.
This article is general educational information about a time-critical emergency and is not a diagnosis, a treatment plan, or a substitute for professional medical advice. It does not promise any outcome from giving or withholding aspirin. Always involve emergency services and a locally qualified clinician in the decision, and if someone is in immediate danger or at risk of self-harm, contact your local emergency number or crisis service without delay.